Adhd - Articles - Page 5 | CARLAT PUBLISHING

Crocus Sativus vs Methylphenidate for ADHD

November 21, 2019

Jess Levy, MD Dr. Levy has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

There are so many alleged herbal remedies touted to treat psychiatric disorders. See our take on this head to head study of Crocus Sativus aka. Saffron versus methylphenidate in ADHD.

Highlights From This Issue

November 15, 2019

Quick hits on what you’ll find in this issue.

Stimulants as Cognitive Enhancers

November 15, 2019

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report.

From the Oval Office to the college dorm, stimulants are often used as performance-enhancing drugs. The ethics of this practice are questionable, but so is the science. New research suggests their pro-cognitive effects are mild at best and come with an unexpected cost on working memory.

FDA Approves Adhansia XR

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this article we discuss a newly FDA-approved formulation for ADHD. Adhansia XR, is a new formulation of extended-release methylphenidate approved by the FDA for the treatment of ADHD in patients 6 years and older.

First Non-Drug Treatment Approved by FDA for Treating Children With ADHD

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In the article we discuss the effectiveness and safety of the first non-drug treatment for ADHD in kids. The FDA has recently granted medical device approval for its external Monarch Trigeminal Nerve Stimulation (eTNS) System for treating kids with ADHD ages 7–12 who are not currently taking medications.

Risk of Psychosis With Stimulants in ADHD Patients

June 11, 2019

Pavan Madan, MD

Pavan Madan, MD Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

As of 2007, the FDA requires stimulant manufacturers to warn of possible psychosis with stimulant use. This article analyzes the results of a 2019 study comparing the risk of psychosis between methylphenidate and amphetamine classes of medications.

Avoiding ADHD Overdiagnosis

May 6, 2019

As more and more patients come to us asking if they have ADHD, we have to be cautious that we are not overdiagnosing the condition. In one study, only 5% of 260 students presenting with possible ADHD symptoms ended up meeting the DSM criteria.At universities, students who are high achievers...

Amphetamines Stand Out in ADHD

March 29, 2019

Michael Posternak, MD.

Michael Posternak, MD.

Dr. Posternak has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

With so many medications available to treat ADHD, wouldn’t it be nice to know if some are better than others? In this comprehensive meta-analysis, researchers sought to compare the relative efficacy and tolerability of both stimulant and non-stimulant medications for ADHD in children and adults.

Medication treatment for ADHD

March 28, 2019

Choosing and prescribing the right medications for treating ADHD can be challenging. The Carlat Child Psychiatry Report spoke with Anne Buchanan, DO, Child psychiatrist at Maimonides Medical Center in Brooklyn, NY, about her approach. She offers the following tips.When choosing meds, Dr. Buchanan recommends that you: Consider stimulants first line.

How Helpful Is Computerized Testing for ADHD?

March 13, 2019

Thomas Jordan, MD.

Thomas Jordan, MD. Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

With busy clinic schedules and the ever-burgeoning load of documentation, computerized diagnostic aids are in more demand than ever. For ADHD, the gold standard is still a clinical assessment with information from parents and teachers, but those reports are difficult to obtain and time-consuming to go through. In these situations, computerized testing may help boost clinical decision-making.